المؤلفون: Christian U. Blank, John B. A. G. Haanen, Doranne L. Hilarius, Michel W. J. M. Wouters, Willeke A. M. Blokx, Franchette W P J van den Berkmortel, Ellen Kapiteijn, Rawa K. Ismail, Geke A. P. Hospers, Jesper van Breeschoten, Alfonsus J. M. van den Eertwegh, Rozemarijn S. van Rijn, Jan Willem B. de Groot, Maureen J.B. Aarts, D Piersma, Astrid A M van der Veldt, G. Vreugdenhil, Marion A. M. Stevense-den Boer, Marye Boers-Sonderen, Karijn P M Suijkerbuijk, Olivier J. van Not, Melissa M. De Meza

المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Medical Oncology, Radiology & Nuclear Medicine, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Internal medicine, Medical oncology, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, Obstetrics and gynaecology, Amsterdam Reproduction & Development (AR&D)

المصدر: International Journal of Cancer, 150(5), 816-824. Wiley
van Not, O J, van Breeschoten, J, van den Eertwegh, A J M, Hilarius, D L, de Meza, M M, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J W B, Hospers, G A P, Ismail, R K, Kapiteijn, E, Piersma, D, van Rijn, R S, Stevense-den Boer, M A M, van der Veldt, A A M, Vreugdenhil, G, Boers-Sonderen, M J, Blokx, W A M, Suijkerbuijk, K P M & Wouters, M W J M 2022, ' The unfavorable effects of COVID-19 on Dutch advanced melanoma care ', International Journal of Cancer, vol. 150, no. 5, pp. 816-824 . https://doi.org/10.1002/ijc.33833Test
International Journal of Cancer, 150, 816-824
International Journal of Cancer, 150, 5, pp. 816-824
International Journal of Cancer, 150(5), 816-824. Wiley-Liss Inc.
International Journal of Cancer, 150(5), 816-824. WILEY
International Journal of Cancer

مصطلحات موضوعية: Adult, Male, advanced melanoma, Cancer Research, Pediatrics, medicine.medical_specialty, Skin Neoplasms, Coronavirus disease 2019 (COVID-19), IMPACT, nationwide registry, Medical care, Systemic therapy, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], systemic therapy, SDG 3 - Good Health and Well-being, COVID‐19, Humans, Medicine, Stage IIIC, Cancer Therapy and Prevention, Melanoma, Aged, Netherlands, Advanced melanoma, Aged, 80 and over, Control period, Performance status, SARS-CoV-2, business.industry, COVID-19, Middle Aged, medicine.disease, clinical outcomes, Oncology, Female, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6999d1436b905ac42aa992a91b031b28Test
https://hdl.handle.net/2066/244556Test

المؤلفون: Olivier J. van Not, Rik J. Verheijden, Alfonsus J. M. van den Eertwegh, John B. A. G. Haanen, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Christian U. Blank, Marye J. Boers-Sonderen, Jan-Willem B. de Groot, Geke A. P. Hospers, Anna M. Kamphuis, Ellen Kapiteijn, Anne M. May, Melissa M. de Meza, Djura Piersma, Rozemarijn van Rijn, Marion A. Stevense-den Boer, Astrid A. M. van der Veldt, Gerard Vreugdenhil, Willeke A. M. Blokx, Michel J. M. Wouters, Karijn P. M. Suijkerbuijk

المساهمون: Medical Oncology, Radiology & Nuclear Medicine, Internal medicine, Medical oncology, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: JAMA Oncology. AMER MEDICAL ASSOC
JAMA Oncology
JAMA Oncology, 8(12), 1794-1801. American Medical Association
van Not, O J, Verheijden, R J, van den Eertwegh, A J M, Haanen, J B A G, Aarts, M J B, van den Berkmortel, F W P J, Blank, C U, Boers-Sonderen, M J, de Groot, J-W B, Hospers, G A P, Kamphuis, A M, Kapiteijn, E, May, A M, de Meza, M M, Piersma, D, van Rijn, R, Stevense-den Boer, M A, van der Veldt, A A M, Vreugdenhil, G, Blokx, W A M, Wouters, M J M & Suijkerbuijk, K P M 2022, ' Association of Immune-Related Adverse Event Management with Survival in Patients with Advanced Melanoma ', JAMA Oncology, vol. 8, no. 12, pp. 1794-1801 . https://doi.org/10.1001/jamaoncol.2022.5041Test
JAMA oncology, 8(12), 1794-1801. AMER MEDICAL ASSOC
Jama Oncology, 8, 12, pp. 1794-1801
Jama Oncology, 8, 1794-1801

مصطلحات موضوعية: Male, Cancer Research, IPILIMUMAB, NIVOLUMAB, Middle Aged, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], Cohort Studies, Immune System Diseases, Oncology, SDG 3 - Good Health and Well-being, Antineoplastic Combined Chemotherapy Protocols, Humans, FAILURE, Female, Steroids, Melanoma, Immunosuppressive Agents, Retrospective Studies, ANTI-TNF

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b26478643297b0e2ad8b55899ada18aTest
http://hdl.handle.net/1887/3564012Test

المؤلفون: Alexander C.J. van Akkooi, Paweł Teterycz, Asier Antoranz, Willeke A. M. Blokx, Francesco Delogu, Bart A. van de Wiel, Senada Koljenović, Martin G. Cook, Piotr Rutkowski, Francesca Maria Bosisio, Daniela Massi, Anna Szumera-Ciećkiewicz, Léon C van Kempen

المساهمون: Pathology

المصدر: European Journal of Cancer, 137, 175-182. ELSEVIER SCI LTD
European Journal of Cancer, 137, 175-182. Elsevier Ltd.

مصطلحات موضوعية: Male, EXPRESSION, 0301 basic medicine, Cancer Research, Pathology, medicine.medical_specialty, Sentinel lymph node, DIAGNOSIS, Metastasis, MALIGNANT-MELANOMA, 03 medical and health sciences, 0302 clinical medicine, True prognostic value, Biopsy, SOX10, medicine, Humans, CELL, IMMUNOHISTOCHEMISTRY, Neoplasm Metastasis, Melanoma, Lymph node, medicine.diagnostic_test, SOXE Transcription Factors, business.industry, S100 Proteins, Myoepithelial cell, Cancer, medicine.disease, TUMORS, FAMILY, WAARDENBURG-SYNDROME, 030104 developmental biology, medicine.anatomical_structure, Oncology, MARKER, 030220 oncology & carcinogenesis, embryonic structures, Female, Lymph, pS100, business, NEOPLASMS

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::139dd51d040f0c1b9e2a2399a372723aTest
https://doi.org/10.1016/j.ejca.2020.06.037Test

المؤلفون: Arjen J. Witkamp, Karijn P M Suijkerbuijk, Carla H. van Gils, Willeke A. M. Blokx, Vigfús Sigurdsson, Annelien E. Laeijendecker, Paul J. van Diest, Mary-Ann El Sharouni

المساهمون: Dermatology

المصدر: El Sharouni, M A, Laeijendecker, A E, Suijkerbuijk, K PM, Witkamp, A J, Sigurdsson, V, van Diest, P J, van Gils, C H & Blokx, W AM 2021, ' High discordance rate in assessing sentinel node positivity in cutaneous melanoma : Expert review may reduce unjustified adjuvant treatment ', European Journal of Cancer, vol. 149, pp. 105-113 . https://doi.org/10.1016/j.ejca.2021.03.001Test
European Journal of Cancer, 149, 105-113. Pergamon

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Clinical Decision-Making, Unnecessary Procedures, Metastasis, 03 medical and health sciences, 0302 clinical medicine, Predictive Value of Tests, Internal medicine, Biopsy, medicine, Adjuvant therapy, Nevus, Humans, False Positive Reactions, Registries, Melanoma, Aged, Neoplasm Staging, Netherlands, Retrospective Studies, Observer Variation, medicine.diagnostic_test, business.industry, Sentinel Lymph Node Biopsy, Patient Selection, Reproducibility of Results, Sentinel node, Middle Aged, medicine.disease, Combined Modality Therapy, Confidence interval, 030104 developmental biology, Treatment Outcome, 030220 oncology & carcinogenesis, Cutaneous melanoma, Female, Sentinel Lymph Node, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03da83b2e334ce20d7e1a364b40c54b0Test
https://research.vumc.nl/en/publications/b351c500-e216-40eb-9581-171d5e1edacfTest

المؤلفون: Willeke A. M. Blokx, Karijn P M Suijkerbuijk, Richard A. Scolyer, Carla H. van Gils, Tasnia Ahmed, Paul J. van Diest, Mary-Ann El Sharouni, Vigfús Sigurdsson, Serigne Lo, Sjoerd G. Elias, Arjen J. Witkamp, Alexander H. R. Varey, John F. Thompson

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39(11)

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Adolescent, MEDLINE, 030207 dermatology & venereal diseases, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Recurrence, Medicine, Humans, In patient, Melanoma, Aged, Aged, 80 and over, business.industry, Distant recurrence, Reproducibility of Results, Nomogram, Middle Aged, Nomograms, Oncology, 030220 oncology & carcinogenesis, Female, Radiology, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d35859757f8a0a36dffa581cd1f5ca7fTest
https://pubmed.ncbi.nlm.nih.gov/33600211Test

المؤلفون: Jan-Willem B de Groot, Christian U. Blank, Doranne H Hilarius, Liesbeth C. de Wreede, Astrid A.M. van der Veldt, Djura Piersma, Ellen Kapiteijn, Franchette W P J van den Berkmortel, Geke A. P. Hospers, Rozemarijn S. van Rijn, Karijn P M Suijkerbuijk, Marye J Boers, Gerard Vreugdenhil, Michel W.J.M. Wouters, Albert J. ten Tije, John B. A. G. Haanen, Maureen J.B. Aarts, Alfons J.M. van den Eertwegh, Willeke A M Blokx, Jesper van Breeschoten

المساهمون: Radiology & Nuclear Medicine, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Obstetrics and gynaecology, Internal medicine, AII - Cancer immunology, CCA - Cancer biology and immunology, CCA - Cancer Treatment and quality of life, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9)

المصدر: van Breeschoten, J, Wouters, M W J M, de Wreede, L C, Hilarius, D H, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J-W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, Blokx, W A M, ten Tije, A J, van der Veldt, A A M, Vreugdenhil, G, Boers, M J & van den Eertwegh, A J M 2021, ' Nationwide Outcomes of Advanced Melanoma According to BRAFV600Status ', American Journal of Clinical Oncology: Cancer Clinical Trials, vol. 44, no. 2, pp. 82-89 . https://doi.org/10.1097/COC.0000000000000786Test
American Journal of Clinical Oncology-Cancer Clinical Trials, 44(2), 82-89. Lippincott Williams & Wilkins
American Journal of Clinical Oncology, 44, 82-89
American Journal of Clinical Oncology, 44, 2, pp. 82-89
American journal of clinical oncology-Cancer clinical trials, 44(2), 82-89. LIPPINCOTT WILLIAMS & WILKINS
American Journal of Clinical Oncology: Cancer Clinical Trials, 44(2), 82-89. Lippincott Williams and Wilkins Ltd.
American Journal of Clinical Oncology, 44(2), 82-89. LIPPINCOTT WILLIAMS & WILKINS
American Journal of Clinical Oncology-Cancer Clinical Trials, 44(2), 82-89. LIPPINCOTT WILLIAMS & WILKINS

مصطلحات موضوعية: Male, Proto-Oncogene Proteins B-raf, advanced melanoma, Cancer Research, medicine.medical_specialty, Immune checkpoint inhibitors, Kaplan-Meier Estimate, B7-H1 Antigen, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], BRAF, 03 medical and health sciences, 0302 clinical medicine, All institutes and research themes of the Radboud University Medical Center, SDG 3 - Good Health and Well-being, Internal medicine, anti-PD-1-ligands, Antineoplastic Combined Chemotherapy Protocols, Overall survival, medicine, Humans, Stage IIIC, CTLA-4 inhibitor, Longitudinal Studies, 030212 general & internal medicine, Melanoma, neoplasms, MEK inhibitors, Aged, Netherlands, Proportional Hazards Models, Advanced melanoma, Aged, 80 and over, Brain Neoplasms, business.industry, National Registry, Hazard ratio, Treatment options, medicine.disease, Confidence interval, Survival Rate, BRAF mutation, Oncology, 030220 oncology & carcinogenesis, Mutation, Female, business, checkpoint inhibitors

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::837893c187a1176e5ed3c58a137cf6f2Test
https://research.vumc.nl/en/publications/09c72104-8257-4b6c-89da-5dc441a033f4Test

المؤلفون: Jesper, van Breeschoten, Michel W J M, Wouters, Doranne L, Hilarius, John B, Haanen, Christian U, Blank, Maureen J B, Aarts, Franchette W P J, van den Berkmortel, Jan-Willem B, de Groot, Geke A P, Hospers, Ellen, Kapiteijn, Djura, Piersma, Roos S, van Rijn, Karijn P M, Suijkerbuijk, Willeke A M, Blokx, Bert-Jan J Ten, Tije, Astrid A M van der, Veldt, Art, Vreugdenhil, Marye J, Boers-Sonderen, Alfonsus J M, van den Eertwegh

المصدر: Br J Cancer

مصطلحات موضوعية: Adult, Aged, 80 and over, Male, Proto-Oncogene Proteins B-raf, Programmed Cell Death 1 Receptor, MAP Kinase Kinase 1, Correction, Middle Aged, Prognosis, Survival Rate, Young Adult, Mutation, Humans, Female, Longitudinal Studies, Prospective Studies, Propensity Score, Melanoma, Protein Kinase Inhibitors, Aged, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid________::6fb24215d2be51efd09ee93525d7d7c6Test
https://pubmed.ncbi.nlm.nih.gov/35256756Test

المؤلفون: Willeke A. M. Blokx, Anne M.L. Jansen, V. Sigurdsson, K. G. P. Kerckhoffs, C. A. Ambarus, T. Aallali

المساهمون: MUMC+: DA Pat AIOS (9), RS: FHML non-thematic output

المصدر: Virchows Archiv
Virchows Archiv, 479(1), 195-202. Springer, Cham

مصطلحات موضوعية: 0301 basic medicine, Male, Pathology, medicine.medical_specialty, Skin Neoplasms, Adolescent, NEVI, MAP Kinase Kinase 1, MELTUMP, Biology, Pathology and Forensic Medicine, 03 medical and health sciences, Genetic signature, 0302 clinical medicine, MAP2K1, Nevus, Epithelioid and Spindle Cell, medicine, Biomarkers, Tumor, Humans, Genetic Predisposition to Disease, Molecular Biology, Melanoma, Aged, MUTATIONS, Brief Report, Cell Biology, General Medicine, Middle Aged, medicine.disease, Spitz nevus, Phenotype, Superficial spreading melanoma, 030104 developmental biology, 030220 oncology & carcinogenesis, Mutation (genetic algorithm), Mutation, KINASE PATHWAY, Immunohistochemistry, Female

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e19e32cf287e957a7fa7a4c2743792e9Test
https://pubmed.ncbi.nlm.nih.gov/33040161Test

المؤلفون: Martin G. Cook, Vincenzo De Giorgi, Caroline Gaudy, Megan E. Grant, Senada Koljenović, Eleanor Kissin, Amaya Viros, Kiarash Khosrotehrani, A. Mandal, Gabriela Gremel, Richard Marais, Daniela Massi, Martin C. Mihm, Willeke A. M. Blokx, Nathalie Dhomen, Joost van den Oord, Adèle C. Green

المساهمون: Pathology

المصدر: Histopathology, 71(6), 943-950. Wiley-Blackwell Publishing Ltd
Histopathology, 71, 943-950
Histopathology, 71, 6, pp. 943-950
Cook, M, Massi, D, Blokx, W A M, van den Oord, J, Koljenovic, S, De Giorgi, V, Kissin, E, Grant, M, Mandal, A, Gremel, G, Gaudy, C, Viros Usandizaga, A, Dhomen, N, Khosrotehrani, K, Marais, R, Green, A & Mihm Jr, M C 2017, ' New insights into naevoid melanomas: a clinicopathological reassessment ', Histopathology . https://doi.org/10.1111/his.13317Test

مصطلحات موضوعية: Adult, Male, Pathology, medicine.medical_specialty, Skin Neoplasms, Histology, Adolescent, Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2], Biology, Pathology and Forensic Medicine, Young Adult, 030207 dermatology & venereal diseases, 03 medical and health sciences, Naevoid melanoma, All institutes and research themes of the Radboud University Medical Center, 0302 clinical medicine, medicine, Humans, Child, Melanoma, neoplasms, Aged, Aged, 80 and over, Nevus, Pigmented, Papilloma, Manchester Cancer Research Centre, Atypical cells, ResearchInstitutes_Networks_Beacons/mcrc, Cancer, General Medicine, Middle Aged, Prognosis, medicine.disease, Dermatology, Superficial spreading melanoma, Small-cell melanoma, 030220 oncology & carcinogenesis, Female

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4d71d7875b5e3e6545a118265e6d3d1Test
https://doi.org/10.1111/his.13317Test

المؤلفون: Djura Piersma, Margreet G. Franken, Geke A. P. Hospers, Jan Willem B. de Groot, Maureen J.B. Aarts, Rozemarijn S. van Rijn, B Leeneman, Marieke W. J. Louwman, Ellen Kapiteijn, Michel W.J.M. Wouters, Alfons J.M. van den Eertwegh, Willeke A. M. Blokx, Franchette W P J van den Berkmortel, Jacobus J.M. van der Hoeven, Hans Gelderblom, John B. A. G. Haanen, Albert J. ten Tije, Gerard Groenewegen, Gerard Vreugdenhil, M Schouwenburg, Mathilde C. Cardous-Ubbink, A Jochems, Carin A. Uyl-de Groot, Rutger H. T. Koornstra, Wim H. J. Kruit

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Health Technology Assessment (HTA), Medical Oncology, Medical oncology, CCA - Evaluation of Cancer Care, Internal medicine

المصدر: European Journal of Cancer, 72, 156-165. ELSEVIER SCI LTD
Jochems, A, Schouwenburg, M G, Leeneman, B, Franken, M G, van den Eertwegh, A J M, Haanen, J B A G, Gelderblom, H, Uyl-de Groot, C A, Aarts, M J B, van den Berkmortel, F W P J, Blokx, W A M, Cardous-Ubbink, M C, Groenewegen, G, de Groot, J W B, Hospers, G A P, Kapiteijn, E, Koornstra, R H, Kruit, W H, Louwman, M W, Piersma, D, van Rijn, R S, Ten Tije, A J, Vreugdenhil, G, Wouters, M W J M & van der Hoeven, J J M 2016, ' Dutch Melanoma Treatment Registry : Quality assurance in the care of patients with metastatic melanoma in the Netherlands ', European Journal of Cancer, vol. 72, pp. 156-165 . https://doi.org/10.1016/j.ejca.2016.11.021Test
European Journal of Cancer, 72, 156-165
European Journal of Cancer, 72, 156. Elsevier Limited
European Journal of Cancer, 72, 156-165. Elsevier Ltd.
European Journal of Cancer, 72, pp. 156-165
European Journal of Cancer, 72, 156-165. Pergamon

مصطلحات موضوعية: Male, INDICATORS, Cancer Research, Skin Neoplasms, Quality Assurance, Health Care, Cost-Benefit Analysis, Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2], Population-based, Systemic therapy, VEMURAFENIB, Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Health care, Registries, 030212 general & internal medicine, Vemurafenib, Melanoma, MUTATION, Netherlands, education.field_of_study, Middle Aged, OPEN-LABEL, CANCER, Quality assurance, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], Oncology, 030220 oncology & carcinogenesis, SAFETY, SURVIVAL, Female, Checkpoint inhibitors, medicine.drug, Adult, medicine.medical_specialty, Registry, Population, Ipilimumab, Cancer Care Facilities, Metastatic melanoma, 03 medical and health sciences, Quality of life (healthcare), Journal Article, medicine, Humans, Intensive care medicine, education, Protein Kinase Inhibitors, Aged, Quality of Health Care, Clinical Audit, business.industry, IPILIMUMAB, Cancer, medicine.disease, Survival Analysis, Surgery, MAP kinase inhibitors, Quality of Life, business, FOLLOW-UP

وصف الملف: application/pdf; image/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1864b94a331d5ff1d6b8ce06aeb92b04Test
https://doi.org/10.1016/j.ejca.2016.11.021Test